Every week we ask ChatGPT, Claude and Gemini the questions real UK consumers ask about pain relief — and record exactly which brands they put forward. Right now, Ibuprofen owns the conversation.
0 AI answers this run · 0 brands named · measured, never estimated
Named in 88% of pain relief answers, typically in position 1.8. Paracetamol follows at 73%, Aspirin at 42%.
Visibility is the share of answers naming the brand; citation share is its slice of all brand-owned pages cited; read→cited is how often its pages convert a read into a citation.
| # | Brand | Visibility | Avg. position | Citation share | Read→cited |
|---|---|---|---|---|---|
| 1 | Ibuprofen | 88% | 1.8 | 0% | — |
| 2 | Paracetamol | 73% | 1.5 | 0% | — |
| 3 | Aspirin | 42% | 3.4 | 0% | — |
| 4 | Well | 33% | 2.4 | 13% | — |
| 5 | Nurofen | 15% | 3.7 | 25% | — |
| 6 | Panadol | 12% | 3.1 | 0% | — |
| 7 | Voltaren | 10% | 2.5 | 0% | — |
| 8 | Voltarol | 10% | 2.5 | 25% | 0% |
| 9 | Boots | 5% | 4.3 | 0% | — |
| 10 | Tiger Balm | 3% | 3.5 | 0% | — |
| 11 | Ibuleve | 3% | 4.0 | 0% | — |
| 12 | Superdrug | 3% | 6.5 | 0% | — |
| 13 | Aleve | 2% | 1.0 | 0% | — |
| 14 | Imigran | 2% | 1.0 | 0% | — |
| 15 | Anadin | 2% | 2.0 | 0% | — |
Being named is visibility. Underneath it, every answer describes a brand in three ways — how much it stands out, how much it belongs, and how much it is returned to. In pain relief, Paracetamol leads attachment at 126 against Ice Storm at 83, indexed on the category at 100.
Each whorl lights one ring per index threshold cleared. See the full pain relief desire edition →
An assistant does not answer from memory alone. It runs its own web searches first, and whoever it searches for is the shortlist it then chooses from. Across 82 searches in pain relief, Ibuprofen is named in 51% of the ones that name a brand at all. ChatGPT Web does not report its searches, so these shares are measured against the ones that do.
These are the assistants' own searches, read from their answers — not what anyone typed into a search engine.
The independent sources AI models cite when answering pain relief questions — the places a brand needs to be seen, reviewed and ranked.
When Claude or ChatGPT opens a brand's own pages while answering, does the page make the cited-sources list? Too little read data in this category so far — the weekly runs will fill this in.
| # | Brand | Visibility | Avg. position | Citation share | Read→cited |
|---|---|---|---|---|---|
| 1 | Ibuprofen | 88% | 1.8 | 0% | — |
| 2 | Paracetamol | 73% | 1.5 | 0% | — |
| 3 | Aspirin | 42% | 3.4 | 0% | — |
| 4 | Well | 33% | 2.4 | 13% | — |
| 5 | Nurofen | 15% | 3.7 | 25% | — |
| 6 | Panadol | 12% | 3.1 | 0% | — |
| 7 | Voltaren | 10% | 2.5 | 0% | — |
| 8 | Voltarol | 10% | 2.5 | 25% | 0% |
| 9 | Boots | 5% | 4.3 | 0% | — |
| 10 | Tiger Balm | 3% | 3.5 | 0% | — |
| 11 | Ibuleve | 3% | 4.0 | 0% | — |
| 12 | Superdrug | 3% | 6.5 | 0% | — |
| 13 | Aleve | 2% | 1.0 | 0% | — |
| 14 | Imigran | 2% | 1.0 | 0% | — |
| 15 | Anadin | 2% | 2.0 | 0% | — |
A rare consensus — every model puts Ibuprofen first, and their top-five lists overlap 67%. Winning here means winning everywhere at once.
Brands whose visibility swings most between models — the bar per model, widest gap on the right.
| Brand | Claude | Gemini | ChatGPT | Spread |
|---|---|---|---|---|
| Paracetamol | 55% | 80% | 85% | 30pp |
| Aspirin | 40% | 30% | 55% | 25pp |
| Nurofen | 10% | 30% | 5% | 25pp |
| Ibuprofen | 80% | 95% | 90% | 15pp |
| Well | 40% | 35% | 25% | 15pp |
| Panadol | 10% | 20% | 5% | 15pp |
| Voltarol | 15% | 10% | 5% | 10pp |
| Voltaren | 15% | 10% | 5% | 10pp |
| Superdrug | 0% | 10% | 0% | 10pp |
| Boots | 0% | 10% | 5% | 10pp |
Every page AI opened while answering, classified by what kind of page it is. Editorial supply the most citations; Comparisons convert best — 93% of the ones models opened were actually cited.
| Page type | Cited | Read but not cited | Conversion |
|---|---|---|---|
| Editorial | 62 | 10 | 86% |
| How-to guides | 57 | 14 | 80% |
| Other | 21 | 12 | 64% |
| Comparisons | 14 | 1 | 93% |
| Product pages | 9 | 1 | 90% |
| Listicles | 9 | 2 | 82% |
| Documentation | 8 | 6 | 57% |
| spec-sheet | 8 | 4 | 67% |
Of the pain relief pages models actually opened, how much more often each feature's pages ended up in the cited sources. Structured data is worth 22 percentage points; hard statistics pages fare 20pp worse. Measured within the read population, so selection can't flatter it.
| Feature | Pages with | Cited % | Pages without | Cited % | Difference |
|---|---|---|---|---|---|
| Structured data | 185 | 86% | 87 | 64% | +22pp |
| Named author | 120 | 83% | 152 | 76% | +7pp |
| Comparison table | 47 | 83% | 225 | 79% | +4pp |
| Updated this year | 57 | 82% | 215 | 79% | +4pp |
| Answer up front | 134 | 81% | 138 | 78% | +2pp |
| Specifications | 36 | 75% | 236 | 80% | -5pp |
| Hard statistics | 58 | 64% | 214 | 84% | -20pp |
Readiness scores each brand's own pages on the structure models reward — a direct answer up front, tables, hard numbers, named authors, structured data, recency, specifications. Asda is the widest gap: well-built pages that still aren't converting into citations.
| Brand | Readiness | Pages cited | Pages profiled |
|---|---|---|---|
| Asda | 33 | 0% | 3 |
| Superdrug | 33 | 0% | 3 |
| Voltarol | 33 | 0% | 66 |
| Nurofen | 32 | 2% | 128 |
| Advil | 25 | 0% | 4 |
| Boots | 22 | 0% | 9 |
| Tesco | 21 | 0% | 3 |
| LloydsPharmacy | 19 | 0% | 8 |
| Well | 18 | 0% | 126 |
| Panadol | 8 | 0% | 39 |
Readiness is the share of eight measurable structural signals present on a brand's profiled pages. It is a build-quality measure, not a ranking of the brand.
Read straight off the pages AI cited: the consumer questions cited content answers most often. Content that fails to settle these is content models have no reason to quote.
Method: 20 unbranded consumer prompts per category, spread across the buying journey, run weekly against ChatGPT, Claude and Gemini. Read→cited uses Claude and ChatGPT only (Gemini does not separate the two). Correlational observations of model behaviour at the time of the run. Data from the run completed Wed, 02 Sep 2026 07:26:05 GMT.